scholarly journals Diet and Behavior Modifications by Long-term Rectal Cancer Survivors to Manage Bowel Dysfunction-Associated Symptoms*

2018 ◽  
Vol 71 (1) ◽  
pp. 89-99
Author(s):  
Virginia Sun ◽  
Christopher S. Wendel ◽  
Wendy Demark-Wahnefried ◽  
Marcia Grant ◽  
Carmit K. McMullen ◽  
...  
2018 ◽  
Vol 36 (7_suppl) ◽  
pp. 141-141
Author(s):  
Virginia Sun ◽  
Tracy E Crane ◽  
Samantha D Slack ◽  
Angela Yung ◽  
Sarah Wright ◽  
...  

141 Background: Rectal cancer survivors often experience persistent long-term effects of treatment. Functional deficits, such as bowel dysfunction, are associated with poor quality of life (QOL). There is a lack of evidence-based interventions to address bowel dysfunction symptoms in rectal cancer survivors. The purpose of this abstract is to describe the development and design of the Altering Intake, Managing Symptoms (AIMS) intervention to manage bowel dysfunction in rectal cancer survivors. Methods: Survivors with stage I-III rectosigmoid colon or rectal cancer who are 6 months post-treatment, > 21 years, and English-speaking are eligible to participate. The AIMS intervention is a ten (30-40 minute) session, 4 month, telephone-based intervention delivered by trained health coaches. Outcome measures are assessed at baseline, 4 and 6 months, and include the MSKCC Bowel Function Tool, the COH-QOL-CRC, and adherence to cancer survivorship diet guidelines. Results: Based on the Chronic Care Self-Management Model (CCM), the AIMS intervention applies social cognitive theory to improve self-efficacy and self-management of bowel symptoms by coaching survivors to modify their diets to attenuate symptoms and enhance diet quality. Motivational interviewing-based behavioral approaches are applied, such as goal setting, self-monitoring, identification of barriers, and problem-solving. Monitoring of diet health involves review of 24 hour dietary recalls in conjunction with food and symptom diaries to promote survivor-directed behavior change resulting in improved bowel health. Conclusions: The AIMS intervention is among the first and few to address diet behavior changes for symptom management in rectal cancer survivors. It has the potential to positively impact the quality of long-term rectal cancer survivorship by integrating classic behavior change theories for cancer symptom management. Findings from the study will inform the design and development of future multi-institutional Phase II and III randomized trials. Clinical trial information: NCT03063918.


2020 ◽  
Vol 24 ◽  
pp. 71-78 ◽  
Author(s):  
Sonja Stieb ◽  
Ismael Perez-Martinez ◽  
Abdallah S.R. Mohamed ◽  
Stockton Rock ◽  
Nimit Bajaj ◽  
...  

2018 ◽  
Vol 68 ◽  
pp. 61-66 ◽  
Author(s):  
Virginia Sun ◽  
Tracy E. Crane ◽  
Samantha D. Slack ◽  
Angela Yung ◽  
Sarah Wright ◽  
...  

2014 ◽  
Vol 23 (10) ◽  
pp. 2831-2840 ◽  
Author(s):  
Christopher S. Wendel ◽  
Marcia Grant ◽  
Lisa Herrinton ◽  
Larissa K. F. Temple ◽  
Mark C. Hornbrook ◽  
...  

2016 ◽  
Vol 13 (7) ◽  
pp. 1071-1079 ◽  
Author(s):  
Virginia Sun ◽  
Marcia Grant ◽  
Christopher S. Wendel ◽  
Carmit K. McMullen ◽  
Joanna E. Bulkley ◽  
...  

2005 ◽  
Vol 23 (25) ◽  
pp. 6199-6206 ◽  
Author(s):  
K.C.M.J. Peeters ◽  
C.J.H. van de Velde ◽  
J.W.H. Leer ◽  
H. Martijn ◽  
J.M.C. Junggeburt ◽  
...  

Purpose Preoperative short-term radiotherapy improves local control in patients treated with total mesorectal excision (TME). This study was performed to assess the presence and magnitude of long-term side effects of preoperative 5 × 5 Gy radiotherapy and TME. Also, hospital treatment was recorded for diseases possibly related to late side effects of rectal cancer treatment. Patients and Methods Long-term morbidity was assessed in patients from the prospective randomized TME trial, which investigated the efficacy of 5 × 5 Gy before TME surgery for mobile rectal cancer. Dutch patients without recurrent disease were sent a questionnaire. Results Results were obtained from 597 patients, with a median follow-up of 5.1 years. Stoma function, urinary function, and hospital treatment rates did not differ significantly between the treatment arms. However, irradiated patients, compared with nonirradiated patients, reported increased rates of fecal incontinence (62% v 38%, respectively; P < .001), pad wearing as a result of incontinence (56% v 33%, respectively; P < .001), anal blood loss (11% v 3%, respectively; P = .004), and mucus loss (27% v 15%, respectively; P = .005). Satisfaction with bowel function was significantly lower and the impact of bowel dysfunction on daily activities was greater in irradiated patients compared with patients who underwent TME alone. Conclusion Although preoperative short-term radiotherapy for rectal cancer results in increased local control, there is more long-term bowel dysfunction in irradiated patients than in patients who undergo TME alone. Rectal cancer patients should be informed on late morbidity of both radiotherapy and TME. Future strategies should be aimed at selecting patients for radiotherapy who are at high risk for local failure.


2012 ◽  
Vol 10 (3) ◽  
pp. 149-150
Author(s):  
M. Hornbrook ◽  
C. McMullen ◽  
J. Bulkley ◽  
C. Wendel ◽  
A. Altschuler ◽  
...  

2012 ◽  
Vol 10 (3) ◽  
pp. 146-146
Author(s):  
C. McMullen ◽  
A. Altschuler ◽  
J. Bulkley ◽  
M. Grant ◽  
M. Hornbrook ◽  
...  

2017 ◽  
Vol 24 (12) ◽  
pp. 3596-3603 ◽  
Author(s):  
Mubarika Alavi ◽  
Christopher S. Wendel ◽  
Robert S. Krouse ◽  
Larissa Temple ◽  
Mark C. Hornbrook ◽  
...  

2015 ◽  
Vol 22 (13) ◽  
pp. 4317-4324 ◽  
Author(s):  
Virginia Sun ◽  
Marcia Grant ◽  
Christopher S. Wendel ◽  
Carmit K. McMullen ◽  
Joanna E. Bulkley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document